 Ampio Pharmaceuticals NYSE American: AMPE, a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, presented March 24, 2021 at the Benzinga Biotech Small Cap Conference. By Mark Gilman 